— Know what they know.
Not Investment Advice

ARKG

ARK Genomic Revolution ETF
1W: +1.1% 1M: +14.4% 3M: +23.8% YTD: +84.9% 1Y: +87.0% 3Y: +92.9% 5Y: -31.0%
$54.00
+0.83 (+1.56%)
 
Weekly Expected Move ±5.6%
$48 $51 $54 $57 $60
ETF CBOE · AUM $1.9B

Portfolio Health Summary

IS Overall Score
41.3
★★★★★
Altman Z-Score
9.65
Safe
Weight Coverage
97%
of portfolio analyzed
Holdings Matched
29
with fundamental data

InsiderStreet Scorecard

★★★★★ 41.3
Profitability
26.4
Balance Sheet
43.6
Earnings Quality
52.3
Growth
53.3
Value
33.9
Momentum
55.4
Safety
78.3

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
9.65
Safe Zone (>2.99)
Piotroski F-Score
4.3 / 9
Moderate
Beneish M-Score
-3.88
Unlikely Manipulator
Credit Score
—
Earnings Quality
52.3 / 100

Portfolio Valuation

P/E
49.66x
P/B
26.03x
P/S
13.84x
EV/EBITDA
32.88x
EV/Revenue
14.33x
P/FCF
63.30x
P/OCF
45.67x
PEG
0.78x
Earnings Yield
2.01%
FCF Yield
1.58%
OCF Yield
2.19%
Median P/E
-12.70x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +11.3%
Net Income +1.5%
EPS +8.5%
FCF -0.2%
EBITDA +30.1%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +5.9%
Rev CAGR 5Y +31.9%
EPS CAGR 3Y +63.4%
EPS CAGR 5Y +15.3%
FCF CAGR 3Y +87.6%
FCF CAGR 5Y +14.6%
EBITDA CAGR 3Y +63.0%
EBITDA CAGR 5Y +17.2%
Payout Ratio
5.06%
Buyback Yield
0.18%
Dividend Yield
0.02%
Total Shareholder Return
-4.25%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$53.95
Median 1Y
$52.64
5th Pctile
$26.68
95th Pctile
$103.80
Ann. Volatility
45.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 49.66
Portfolio P/B 26.03
Portfolio P/S 13.84
EV/EBITDA 32.88
EV/Revenue 14.33
P/FCF 63.30
P/OCF 45.67
PEG 0.78
Earnings Yield 2.01%
FCF Yield 1.58%
OCF Yield 2.19%
Median P/E -12.70
Profitability & Returns (9)
MetricValue
Gross Margin 81.60%
Operating Margin 34.81%
Net Margin 22.81%
FCF Margin 17.81%
ROE 51.44%
ROA 14.47%
ROIC 29.33%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.29
Debt/Assets 0.38
Net Debt/EBITDA 0.95
Interest Coverage 21.93
Current Ratio 1.64
Quick Ratio 1.31
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 11.29%
Net Income Growth 1.50%
EPS Growth 8.52%
FCF Growth -0.16%
EBITDA Growth 30.15%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 5.87%
Revenue CAGR 5Y 31.87%
Revenue CAGR 10Y —
EPS CAGR 3Y 63.45%
EPS CAGR 5Y 15.31%
EPS CAGR 10Y —
FCF CAGR 3Y 87.61%
FCF CAGR 5Y 14.57%
FCF CAGR 10Y —
EBITDA CAGR 3Y 62.98%
EBITDA CAGR 5Y 17.25%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 60.19%
Net Income CAGR 5Y 15.56%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 41.3
IS Profitability 26.4
IS Balance Sheet 43.6
IS Earnings Quality 52.3
IS Growth 53.3
IS Value 33.9
IS Momentum 55.4
IS Safety 78.3
IS Quality 46.3
Altman Z-Score 9.65
Piotroski F-Score 4.31
Beneish M-Score -3.88
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.02%
Payout Ratio 5.06%
Buyback Yield 0.18%
Total Shareholder Return -4.25%
Growth Stability (4)
MetricValue
Revenue Stability 0.761
Earnings Stability 0.361
Earnings Persistence 0.734
Margin Stability 0.659
Medians (3)
MetricValue
Median P/E -12.70
Median P/B 7.09
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 97.18%
Holdings Matched 29
Total Holdings 32

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms